NDC 54973-4086 – Bioplasma

Silicon Dioxide 6 [hp_X]/1; Tribasic Calcium Phosphate 3 [hp_X]/1; Ferrosoferric Phosphate 3 [hp_X]/1; Magnesium Phosphate, Dibasic Trihydrate 3 [hp_X]/1;… · Tablet, Soluble · Oral

Human Otc Drug

Product NDC54973-4086

Product details

Brand name
Bioplasma
Generic name
Silicon Dioxide,potassium Chloride,sodium Sulfate,ferrosoferric Phosphate,magnesium Phosphate, Dibasic Trihydrate,sodium Phosphate, Dibasic, Heptahydrate,tribasic Calcium Phosphate,potassium Phosphate, Dibasic,potassium Sulfate,sodium Chloride,calcium Sulfate Anhydrous,calcium Fluoride
Labeler
Hyland's Inc.
Dosage form
Tablet, Soluble
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
December 6, 2021
Listing expires
December 31, 2027
Pharmacologic class
Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Osmotic Laxative; Osmotic Laxative; Osmotic Laxative; Osmotic Laxative; Phosphate Binder; Potassium Salt

Active ingredients

Uses, dosage, side effects and warnings for Bioplasma →

Package NDC codes (1)

Package NDCDescriptionSince
54973-4086-11 BOTTLE, PLASTIC in 1 CARTON (54973-4086-1) / 100 TABLET, SOLUBLE in 1 BOTTLE, PLASTICDec 6, 2021